A Missense Mutation in the Cholesteryl Ester Transfer Protein Gene with Possible Dominant Effects on Plasma High Density Lipoproteins

Overview

Journal J Clin Invest

Specialty General Medicine

Date 1993 Oct 1

PMID 8408659

Citations 25

Authors

K Takahashi

X C Jiang

N Sakai

S Yamashita

K Hirano

H Bujo

H Yamazaki

J Kusunoki

T Miura

P Kussie

Affiliations

Soon will be listed here.

Abstract

Plasma HDL are a negative risk factor for atherosclerosis. Cholesteryl ester transfer protein (CETP; 476 amino acids) transfers cholesteryl ester from HDL to other lipoproteins. Subjects with homozygous CETP deficiency caused by a gene splicing defect have markedly elevated HDL; however, heterozygotes have only mild increases in HDL. We describe two probands with a CETP missense mutation (442 D:G). Although heterozygous, they have threefold increases in HDL concentration and markedly decreased plasma CETP mass and activity, suggesting that the mutation has dominant effects on CETP and HDL in vivo. Cellular expression of mutant cDNA results in secretion of only 30% of wild type CETP activity. Moreover, coexpression of wild type and mutant cDNAs leads to inhibition of wild type secretion and activity. The dominant effects of the CETP missense mutation during cellular expression probably explains why the probands have markedly increased HDL in the heterozygous state, and suggests that the active molecular species of CETP may be multimeric.

Citing Articles

Maculopathies: A Systematic Literature Review on Pathophysiology, Public Health, and Treatment.

Pantelidou M, Sunnucks D, Pantelidis E Cureus. 2025; 16(12):e74911.

PMID: 39742182 PMC: 11687407. DOI: 10.7759/cureus.74911.

Variants in the CETP gene affect levels of HDL cholesterol by reducing the amount, and not the specific lipid transfer activity, of secreted CETP.

Olnes A, Teigen M, Laerdahl J, Leren T, Strom T, Bjune K PLoS One. 2023; 18(12):e0294764.

PMID: 38039300 PMC: 10691695. DOI: 10.1371/journal.pone.0294764.

Dissecting the Structural Dynamics of Authentic Cholesteryl Ester Transfer Protein for the Discovery of Potential Lead Compounds: A Theoretical Study.

Zhao Y, Hao D, Zhao Y, Zhang S, Zhang L, Yang Z Int J Mol Sci. 2023; 24(15).

PMID: 37569628 PMC: 10418423. DOI: 10.3390/ijms241512252.

Association of lipid metabolism-related gene promoter methylation with risk of coronary artery disease.

Li W, Wang Y, Huang R, Lian F, Xu G, Wang W Mol Biol Rep. 2022; 49(10):9373-9378.

PMID: 35941416 DOI: 10.1007/s11033-022-07789-0.

Is a High HDL-Cholesterol Level Always Beneficial?.

Franczyk B, Rysz J, Lawinski J, Rysz-Gorzynska M, Gluba-Brzozka A Biomedicines. 2021; 9(9).

PMID: 34572269 PMC: 8466913. DOI: 10.3390/biomedicines9091083.

References

Drayna D, Jarnagin A, McLean J, Henzel W, Kohr W, Fielding C . Cloning and sequencing of human cholesteryl ester transfer protein cDNA. Nature. 1987; 327(6123):632-4. DOI: 10.1038/327632a0. View

Hesler C, Swenson T, Tall A . Purification and characterization of a human plasma cholesteryl ester transfer protein. J Biol Chem. 1987; 262(5):2275-82. View

Swenson T, Brocia R, Tall A . Plasma cholesteryl ester transfer protein has binding sites for neutral lipids and phospholipids. J Biol Chem. 1988; 263(11):5150-7. View

Whitlock M, Swenson T, Ramakrishnan R, Leonard M, Marcel Y, Milne R . Monoclonal antibody inhibition of cholesteryl ester transfer protein activity in the rabbit. Effects on lipoprotein composition and high density lipoprotein cholesteryl ester metabolism. J Clin Invest. 1989; 84(1):129-37. PMC: 303962. DOI: 10.1172/JCI114132. View

Brown M, Inazu A, Hesler C, Agellon L, Mann C, Whitlock M . Molecular basis of lipid transfer protein deficiency in a family with increased high-density lipoproteins. Nature. 1989; 342(6248):448-51. DOI: 10.1038/342448a0. View

Hurtley S, Helenius A . Protein oligomerization in the endoplasmic reticulum. Annu Rev Cell Biol. 1989; 5:277-307. DOI: 10.1146/annurev.cb.05.110189.001425. View

Agellon L, Quinet E, Gillette T, Drayna D, Brown M, Tall A . Organization of the human cholesteryl ester transfer protein gene. Biochemistry. 1990; 29(6):1372-6. DOI: 10.1021/bi00458a004. View

Prockop D . Mutations that alter the primary structure of type I collagen. The perils of a system for generating large structures by the principle of nucleated growth. J Biol Chem. 1990; 265(26):15349-52. View

Yamashita S, Sprecher D, Sakai N, Matsuzawa Y, Tarui S, Hui D . Accumulation of apolipoprotein E-rich high density lipoproteins in hyperalphalipoproteinemic human subjects with plasma cholesteryl ester transfer protein deficiency. J Clin Invest. 1990; 86(3):688-95. PMC: 296782. DOI: 10.1172/JCI114764. View

10.

Inazu A, Brown M, Hesler C, Agellon L, Koizumi J, Takata K . Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation. N Engl J Med. 1990; 323(18):1234-8. DOI: 10.1056/NEJM199011013231803. View

11.

Sykes B . Human genetics. Bone disease cracks genetics. Nature. 1990; 348(6296):18-20. DOI: 10.1038/348018a0. View

12.

Sakai N, Matsuzawa Y, Hirano K, Yamashita S, Nozaki S, Ueyama Y . Detection of two species of low density lipoprotein particles in cholesteryl ester transfer protein deficiency. Arterioscler Thromb. 1991; 11(1):71-9. DOI: 10.1161/01.atv.11.1.71. View

13.

Savolainen M, Hannuksela M, Seppanen S, Kervinen K, Kesaniemi Y . Increased high-density lipoprotein cholesterol concentration in alcoholics is related to low cholesteryl ester transfer protein activity. Eur J Clin Invest. 1990; 20(6):593-9. DOI: 10.1111/j.1365-2362.1990.tb01906.x. View

14.

Agellon L, Walsh A, Hayek T, Moulin P, Jiang X, Shelanski S . Reduced high density lipoprotein cholesterol in human cholesteryl ester transfer protein transgenic mice. J Biol Chem. 1991; 266(17):10796-801. View

15.

Yamashita S, Hui D, Wetterau J, Sprecher D, Harmony J, Sakai N . Characterization of plasma lipoproteins in patients heterozygous for human plasma cholesteryl ester transfer protein (CETP) deficiency: plasma CETP regulates high-density lipoprotein concentration and composition. Metabolism. 1991; 40(7):756-63. DOI: 10.1016/0026-0495(91)90097-g. View

16.

Hirano K, Matsuzawa Y, Sakai N, Hiraoka H, Nozaki S, Funahashi T . Polydisperse low-density lipoproteins in hyperalphalipoproteinemic chronic alcohol drinkers in association with marked reduction of cholesteryl ester transfer protein activity. Metabolism. 1992; 41(12):1313-8. DOI: 10.1016/0026-0495(92)90101-f. View

17.

Wang S, Wang X, Deng L, Rassart E, Milne R, Tall A . Point mutagenesis of carboxyl-terminal amino acids of cholesteryl ester transfer protein. Opposite faces of an amphipathic helix important for cholesteryl ester transfer or for binding neutralizing antibody. J Biol Chem. 1993; 268(3):1955-9. View

18.

Inazu A, Koizumi J, Haraki T, Yagi K, Wakasugi T, TAKEGOSHI T . Rapid detection and prevalence of cholesteryl ester transfer protein deficiency caused by an intron 14 splicing defect in hyperalphalipoproteinemia. Hum Genet. 1993; 91(1):13-6. DOI: 10.1007/BF00230214. View

19.

Hirano K, Yamashita S, Funahashi T, Sakai N, Menju M, Ishigami M . Frequency of intron 14 splicing defect of cholesteryl ester transfer protein gene in the Japanese general population--relation between the mutation and hyperalphalipoproteinemia. Atherosclerosis. 1993; 100(1):85-90. DOI: 10.1016/0021-9150(93)90070-b. View

20.

Rhoads G, Gulbrandsen C, Kagan A . Serum lipoproteins and coronary heart disease in a population study of Hawaii Japanese men. N Engl J Med. 1976; 294(6):293-8. DOI: 10.1056/NEJM197602052940601. View